Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 29, 2021

Primary Completion Date

May 17, 2022

Study Completion Date

May 17, 2022

Conditions
Corneal Diseases
Interventions
DRUG

ZKY001 EYE DROPS

"On the 1st postoperative day (Day1), ZKY001 eye drops were dropped into the experimental eyes (the operative eyes were taken as the experimental eyes). ZKY001 eye drops were given at 8:00 am ±1h from Day1 to Day5. 4 times a day, 1 drop each time, recommended interval of 4 to 6 hours.~Day6 was administered at 8:00 am ±1h, and ZKY001 eye drops were dropped into the test eye (the surgical eye was taken as the test eye). Day6 was given only once, 1 drop each time."

Trial Locations (1)

BJ10

Zhiqiang Pan, Beijing

All Listed Sponsors
lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY

NCT07132437 - Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect | Biotech Hunter | Biotech Hunter